Literature DB >> 23466070

APOE genotype modifies the association between plasma omega-3 fatty acids and plasma lipids in the Multi-Ethnic Study of Atherosclerosis (MESA).

Shuang Liang1, Lyn M Steffen, Brian T Steffen, Weihua Guan, Natalie L Weir, Stephen S Rich, Ani Manichaikul, Jose D Vargas, Michael Y Tsai.   

Abstract

OBJECTIVE: The benefits of fish oil fatty acids eicosapentaenoic (EPA) and docosahexaenoic acids (DHA) on plasma lipid profiles have been inconsistent but may partially depend on individual Apolipoprotein E (APOE) genotypes. We aimed to determine whether APOE genotype modifies the association of lipid profile characteristics with plasma EPA and DHA levels.
METHODS: APOE genotype was determined in this cross-sectional analysis of 2340 Multi-Ethnic Study of Atherosclerosis (MESA) participants. Relative plasma phospholipid EPA and DHA levels, plasma lipids, and lipoprotein subclass particle sizes and concentrations were measured.
RESULTS: Significant gene-EPA interactions were found with HDL-C, and particle concentrations of large and total HDL (p(interaction) = 0.0002, 0.006, and 0.007, respectively). The above lipid targets were positively associated with EPA in the E2 groups, whereas negative trends were observed among the E4 participants. Gene-DHA interactions were noted for small LDL particle concentrations alone (p(interaction) = 0.01), where a positive trend was found among E4 but not E2 or E3 participants.
CONCLUSIONS: These results indicate a significant contribution of the APOE genotype to the EPA-lipid profile relationship; however, the results do not explain the differences in previous findings regarding LDL-C, triglycerides or total cholesterol. Future investigators examining the effects of EPA on HDL-C or lipoprotein characteristics may consider including APOE genotype in their analyses.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23466070      PMCID: PMC3640761          DOI: 10.1016/j.atherosclerosis.2013.02.004

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  55 in total

1.  ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype.

Authors:  A M Minihane; S Khan; E C Leigh-Firbank; P Talmud; J W Wright; M C Murphy; B A Griffin; C M Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

Review 2.  The cell biology and physiologic relevance of ApoE recycling.

Authors:  S Fazio; M F Linton; L L Swift
Journal:  Trends Cardiovasc Med       Date:  2000-01       Impact factor: 6.677

3.  Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers.

Authors:  E Dewailly E; C Blanchet; S Gingras; S Lemieux; L Sauvé; J Bergeron; B J Holub
Journal:  Am J Clin Nutr       Date:  2001-11       Impact factor: 7.045

4.  Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype.

Authors:  Syrah Khan; Anne-Marie Minihane; Philippa J Talmud; John W Wright; Margaret C Murphy; Christine M Williams; Bruce A Griffin
Journal:  J Lipid Res       Date:  2002-06       Impact factor: 5.922

5.  n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik.

Authors:  E Dewailly; C Blanchet; S Lemieux; L Sauvé; S Gingras; P Ayotte; B J Holub
Journal:  Am J Clin Nutr       Date:  2001-10       Impact factor: 7.045

Review 6.  Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction.

Authors:  T A Mori; L J Beilin
Journal:  Curr Opin Lipidol       Date:  2001-02       Impact factor: 4.776

7.  N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.

Authors:  Heiner C Bucher; Peter Hengstler; Christian Schindler; Gabriela Meier
Journal:  Am J Med       Date:  2002-03       Impact factor: 4.965

Review 8.  n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases.

Authors:  Philip C Calder
Journal:  Am J Clin Nutr       Date:  2006-06       Impact factor: 7.045

9.  Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree.

Authors:  Eric Dewailly; Carole Blanchet; Suzanne Gingras; Simone Lemieux; Bruce John Holub
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

10.  Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study.

Authors:  Muriel J Caslake; Elizabeth A Miles; Bettina M Kofler; Georg Lietz; Peter Curtis; Christopher K Armah; Alan C Kimber; Jilly P Grew; Lesley Farrell; Julie Stannard; Frances L Napper; Aleix Sala-Vila; Annette L West; John C Mathers; Christopher Packard; Christine M Williams; Philip C Calder; Anne M Minihane
Journal:  Am J Clin Nutr       Date:  2008-09       Impact factor: 7.045

View more
  15 in total

1.  Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.

Authors:  H K Lückhoff; M Kidd; S J van Rensburg; D P van Velden; M J Kotze
Journal:  Metab Brain Dis       Date:  2016-02       Impact factor: 3.584

2.  Heterogeneity in 14-year Dementia Incidence Between Asian American Subgroups.

Authors:  Elizabeth R Mayeda; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jul-Sep       Impact factor: 2.703

3.  APOE and the Association of Fatty Acids With the Risk of Stroke, Coronary Heart Disease, and Mortality.

Authors:  Claudia L Satizabal; Cécilia Samieri; Kendra L Davis-Plourde; Barbara Voetsch; Hugo J Aparicio; Matthew P Pase; José Rafael Romero; Catherine Helmer; Ramachandran S Vasan; Carlos S Kase; Stéphanie Debette; Alexa S Beiser; Sudha Seshadri
Journal:  Stroke       Date:  2018-12       Impact factor: 7.914

4.  Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).

Authors:  Eric M Ammann; James V Pottala; Jennifer G Robinson; Mark A Espeland; William S Harris
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-06-15       Impact factor: 4.006

5.  Associations among vascular risk factors, neuroimaging biomarkers, and cognition: Preliminary analyses from the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Samuel N Lockhart; Christopher L Schaich; Suzanne Craft; Bonnie C Sachs; Stephen R Rapp; Youngkyoo Jung; Christopher T Whitlow; Kiran Kumar Solingapuram Sai; Maryjo Cleveland; Benjamin J Williams; Gregory L Burke; Alain Bertoni; Kathleen M Hayden; Timothy M Hughes
Journal:  Alzheimers Dement       Date:  2021-09-05       Impact factor: 16.655

Review 6.  Quantile-Dependent Expressivity and Gene-Lifestyle Interactions Involving High-Density Lipoprotein Cholesterol.

Authors:  Paul T Williams
Journal:  Lifestyle Genom       Date:  2020-12-09

Review 7.  Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update.

Authors:  Esther M M Ooi; Gerald F Watts; Theodore W K Ng; P Hugh R Barrett
Journal:  Nutrients       Date:  2015-06-02       Impact factor: 5.717

Review 8.  Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease?

Authors:  Raphaël Chouinard-Watkins; Mélanie Plourde
Journal:  Nutrients       Date:  2014-10-20       Impact factor: 5.717

9.  Personalized lifestyle medicine: relevance for nutrition and lifestyle recommendations.

Authors:  Deanna M Minich; Jeffrey S Bland
Journal:  ScientificWorldJournal       Date:  2013-06-26

10.  Does APOE genotype modify the relations between serum lipid and erythrocyte omega-3 fatty acid levels?

Authors:  William S Harris; James V Pottala; Dawn L Thiselton; Stephen A Varvel; Alison M Baedke; Thomas D Dayspring; G Russell Warnick; Joseph P McConnell
Journal:  J Cardiovasc Transl Res       Date:  2014-03-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.